Costales ED, Lima DAJ, Marcell RL

Language: Spanish
References: 9
Page: 1-4
PDF size: 229.77 Kb.

Text Extraction

No abstract.

REFERENCES

1. Jansen MA, van den Heuvel D, Bouthoorn SH, Jaddoe VW, Hooijkaas H, Raat H, et al1. . Determinants of Ethnic Differences in Cytomegalovirus, Epstein-Barr Virus, and Herpes Simplex Virus Type 1 Seroprevalence in Childhood. J Pediatr. 2016;170:126-34.e1-6. DOI: https://10.1016/j.jpeds.2015.11.0141. . Jansen MA, van den Heuvel D, Bouthoorn SH, Jaddoe VW, Hooijkaas H, Raat H, et al. Determinants of Ethnic Differences in Cytomegalovirus, Epstein-Barr Virus, and Herpes Simplex Virus Type 1 Seroprevalence in Childhood. J Pediatr. 2016;170:126-34.e1-6. DOI: https:// 10.1016/j.jpeds.2015.11.014

2. Ferrés M, Nervi B, Ramírez P. Profilaxis de citomegalovirus en niños y adultos sometidos a trasplante de órganos sólidos y de precursores hematopoyéticos. Rev Chil Infectol. 2012;29:23-8. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182012000500004&nrm=iso2.

3. . Jaime-Fagundo J, Castellanos-Hernández L, Díaz-Marrero J, Sarduy-Saez S, Llerena-Moreno D, Roque-García W. Las infecciones en niños receptores de trasplante de progenitores hematopoyéticos. Instituto de Hematología e Inmunología. 1986-2016. Rev Cubana Hematol Inmunol Hemoter. 2018;34(4). Disponible en: http://www.revhematologia.sld.cu/index.php/hih/article/view/9403.

4. . Costales Elizaldes D, Morera Barrios L, González García N, Chang Monteagudo A, Marcell Rodríguez L, Ustariz García CR, et al. Anticuerpos anticitomegalovirus y antivirus de Epstein Barr en pacientes cubanos en espera de trasplante hematopoyético. Rev Cubana Hematol Inmunol Hemoter. 2017;33(2). Disponible en: http://www.revhematologia.sld.cu/index.php/hih/article/view/5494.

5. Zhou X, Jin N, Chen B. Human cytomegalovirus infection: A considerable issue following allogeneic hematopoietic stem cell transplantation. Oncol Lett. 2021;21(4):318. DOI: https://10.3892/ol.2021.125795.

6. Shafat MS, Mehra V, Peggs KS, Roddie C. Cellular Therapeutic Approaches to Cytomegalovirus Infection Following Allogeneic Stem Cell Transplantation. Front Immunol. 2020;11:1694. DOI: https://10.3389/fimmu.2020.016946.

7. Ljungman P, de la Camara R, Robin C, Crocchiolo R, Einsele H, Hill JA, et al. Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis. 2019; 19(8):e260-e72 DOI: https://10.1016/s1473-3099(19)30107-07.

8. Marinho-Dias J, Lobo J, Henrique R, Baldaque I, Pinho-Vaz C, Regadas L, et al. Post-transplant lymphoproliferative disorder in hematopoietic stem cell transplant patients: A single center retrospective study between 2005 and 2012. Mol Med Rep. 2018;18(5):4650-6. DOI: https://10.3892/mmr.2018.94338.

9. Kolodziejczak M, Gil L, de la Camara R, Styczynski J. Impact of donor and recipient Epstein-Barr Virus serostatus on outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis. Ann Hematol 2021;100(3):763-77. DOI: https://10.1007/s00277-021-04428-99.